Clinical Trial: Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional




Official Title: Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease

Brief Summary: The purpose of this trial is to evaluate whether, in Intravenous Immunoglobulin-naïve or refractory patients diagnosed with active Kawasaki disease, administration of canakinumab controls fever and acute phase reactants.